SlideShare ist ein Scribd-Unternehmen logo
1 von 20
Downloaden Sie, um offline zu lesen
PharmaForce International Inc.
Insightful Intelligence with a Global Reach
Corporate Headquarters
2645 Perkiomen Avenue • Reading, PA 19606 • (610) 370-5640 • Fax (610) 370-5641 • www.pharmaforce.biz
Competitive Analysis and
Market Research Capabilities
2013
1
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
About PharmaForce International
Copyright 2013 by PharmaForce International R E A D I N G, P A
Specialists in competitive
intelligence for the
pharmaceutical, biotech and
medical device industries
Global leaders in identifying
“everything and anything” that
pharmaceutical and biotech
companies want to know
about the operations of their
competitors
• Competitive Monitoring
• Syndicated Studies
• Proprietary Projects
2
About PharmaForce International (cont’d)
• Multi-lingual staff with direct experience in the pharmaceutical industry and
business intelligence
– Hundreds of years of combined industry experience as Sales Representatives,
District Managers, Product Managers, Medical Information Specialists, Market
Research Directors, Clinical Trial Coordinators, Business Analysts, Medical
Liaisons and Country Business Unit Directors
• Primary research capabilities, including the following languages:
- Arabic - Italian
- Chinese - Japanese
- Croatian - Mandarin
- Dutch - Portuguese
- English - Russian
- French - Serbian
- German - Slovenian
- Hindi - Spanish
Copyright 20123by PharmaForce International R E A D I N G, P A
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Examples of Countries Where PharmaForce Conducts
Research
Algeria Germany Poland
Argentina Greece Portugal
Australia Hong Kong Russia
Austria Korea Saudi Arabia
Belgium India South Africa
Brazil Ireland Spain
Canada Italy Sweden
China Japan Switzerland
Colombia Luxembourg Thailand
Denmark Mexico Turkey
Egypt Morocco United Kingdom
Finland Netherlands United States
France Norway Venezuela
Copyright 2013 by PharmaForce International R E A D I N G, P A 3
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
4
Selection of PharmaForce International‘s Clients
Copyright 2013 by PharmaForce International R E A D I N G, P A
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
PharmaForce’s 360 Program
• PharmaForce specializes in providing clients with a 360 perspective on the
marketplace for their drugs
Copyright 2013 by PharmaForce International R E A D I N G, P A 5
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Benchmarking capabilities include:
- Sales force deployment - Target audience focus
- Detailing intensity analysis (DIA) - Marketing expenditures for key drugs
- Compensation plans - Key Account management personnel
- Role of Medical Liaisons - Training programs
- Product portfolio management, including FTEs by product
- Medical Affairs structures and organizational approaches
- Sales and Marketing structures and organizational approaches
PharmaForce’s 360 Program (cont’d)
• Pick and choose from the capabilities menu or receive tremendous cost savings
by packaging a full suite of service
• Our competitive intelligence capabilities track strategic planning through brand/
market assessments as well as therapeutic area outlooks
Copyright 2013 by PharmaForce International R E A D I N G, P A 6
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Customer perception surveys Business research capabilities
- KOL assessment - Sales force effectiveness
- High prescriber perception analysis - Convention analysis and monitoring
- Target physician audience profiling - Pipeline assessments
Research Techniques
• Unique combination of field research methodologies can be utilized in any
therapeutic area(s)
 Unstructured peer interviews conducted by professional staff
 Questionnaire web-based surveys
 Highly detailed benchmarking questionnaires
 Expert panels
• Through these survey techniques, PharmaForce has the ability to rapidly
develop product and commercial strategy perceptions from key customer
constituencies, such as:
 KOLs
 Physicians
 High prescribers
Copyright 2013 by PharmaForce International R E A D I N G, P A 7
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Field-Tested Primary Source Research Approach
Copyright 2013 by PharmaForce International R E A D I N G, P A
 More than 90% of the information for any project is derived from one-on-one
interviews with individuals in the industry
• Includes current and former employees of target organizations
 Interviewers draw a common bond with interview targets and engage in peer-to-
peer discussions about topics of common interest
• Supplemented with searches of all relevant electronic and printed
databases, including PharmaForce’s proprietary databases developed over
the past two decades
8
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Database of qualified
contacts in the
pharmaceutical industry
exceeds 50,000
worldwide
Includes personnel in
almost every sales and
marketing function from
sales representatives to
senior management
Field-Tested Primary Source Research Approach
(cont’d)
Copyright 2013 by PharmaForce International R E A D I N G, P A 9
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
• Strong interviewing skills come into play with the
middle 50% as key partial pieces of data are culled
from their limited responses
• Ability to trade data on previously researched
companies dramatically increases level of
cooperation
Typically, 25% of
interviewees participate
willingly, while another 25%
refuse to participate
• One-on-one discussions with multiple
knowledgeable sources result in verification of
data
• Previous research experience on the topics allows
for the widest possible knowledge base of the
target deliverables and key resources
Triangulation of data from
contacts who are customers,
suppliers and company
employees results in
multiple confirmations of
findings from all
perspectives
All employees participate in an ongoing training program to improve interviewing
techniques and identify the latest trends in the industry
Member of PBIRG and EphMRA
Interviewing Methodology
Copyright 2013 by PharmaForce International R E A D I N G, P A
Target
company
Competitors
Former employees
Clinical trial investigators
Formulary managers
Advertising agencies
Physicians, thought leaders, hospitals
and other medical personnel
Advocacy and cooperative groups, convention personnel,
CME development firms, etc.
Existing database
10
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Competitive Advantages of Using PharmaForce
Copyright 2013 by PharmaForce International R E A D I N G, P A
Key competitive advantages of utilizing PharmaForce for your competitive
analysis and market research needs include:
11
Pharma industry-
experienced staff
who are veterans of
hundreds of projects
in the pharmaceutical
and biotech
industries
One-on-one
interviewing with
KOLs, physicians
and patients to obtain
the full perspective
on your therapeutic
area
Customized
reports
available to
target any
company,
country,
therapy
area and
brand of
interest!
Established
relationships with
over 50,000 industry
personnel to gain
crucial insights on
your key competitors
360° view into
internal structures,
market spending,
insights, benchmarks
and best practices of
industry leaders
worldwide
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Why Companies Use PharmaForce’s Studies
Copyright 2013 by PharmaForce International R E A D I N G, P A 12
Maximize the success of product
launches through key messaging
Increase sales force
effectiveness
Allocate marketing
resources
Restructure/expand/add sales
forces or other departments
Satisfy the needs of key
customer constituencies
Understand aspects of lifecycle
management and product
position
Overall,
PharmaForce’s
studies provide
more
information to
better deploy
resources
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
“Your oncology sales force and marketing expenditure benchmarking is the gold standard
in the industry. Our company has purchased the study for 6 consecutive years and could
not determine our marketing budgets or sales force POAs without it”
– Global Market Research Director, Top 5 Pharma Company
“PharmaForce’s competitive intelligence data is by far the most accurate data that we
have ever used. Senior management love it. We would not use any other competitive
intelligence firm”
– Market Intelligence Director, Billion Dollar Specialty Pharma Company
“Once we used PharmaForce’s benchmarking data in one therapeutic area, I immediately
knew that we had to use it in every other therapeutic area in our company”
– Director, Global Market Analytics, Top 10 Pharma Company
“PharmaForce works within this company’s budget constraints to provide partial data
from multiple syndicated studies”
– Up-and-coming biotech company launching its first drug
Client Testimonials
Copyright 2013 by PharmaForce International R E A D I N G, P A 13
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
Assisting an Emerging Biotech Assess the Competitive Landscape for the First Time and
Develop Recommendations for Establishing a Commercial Presence in 6 Different Countries
Worldwide
Benchmarking of Marketing Expenditures by Product or Franchise
Analysis of Drug Launch Plans
Assessment of Potential Biotech Partnership/Acquisition Opportunities
Competitive Assessment of Patient Marketing Programs and Materials
Analysis of Medical Services Departments Globally
Health Economics Outcomes Research (HEOR) Strategies
Benchmarking of the Managed Care Function at Leading Pharma Companies
Assessment of KOL Opinions on Best Practices in Advisory Board Sessions
Competitive Monitoring of the U.S. Vaccines Market
Analysis of Clinical Trial and Phase IV Strategies for Select Products
Analysis of Sampling Programs and Detailing Messages
Benchmarking of the Medical Affairs Function Supporting Leading Products
Benchmarking of Speakers’ Bureaus and Advisory Board Management
Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Targeting the
Hospital/IDN Market Customer
Examples of Types of Studies Conducted by
PharmaForce
Copyright 2013 by PharmaForce International R E A D I N G, P A 14
COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
15
PharmaForce International Global Deployment Analyzer: a powerful web-based program
that allow clients to access up-to-date information on leading pharmaceutical sales
forces around the globe at www.deploymentanalyzer.com
– 60 leading companies’ sales forces in the United States
– 25 leading companies’ sales forces in 10 countries in Europe
– 25 leading companies’ sales forces in Japan
– 12 leading companies’ sales forces in Argentina, Brazil and Mexico
– 13 leading companies’ sales forces in India
Competitive Benchmarking of Leading Oncology Sales and Marketing Organizations,
providing worldwide perspective on sales and marketing operations of leading oncology
competitors around the globe
– 14 leading companies in 5 countries in Europe
– 21 leading companies in the United States
– 11 leading companies in Japan
– 10 leading companies in 4 countries in Latin America
List of Syndicated Studies
Copyright 2013 by PharmaForce International R E A D I N G, P A
OVERALL ASSESSMENT
16
Competitive Benchmarking of Leading Multiple Sclerosis Sales and Marketing
Organizations, covering commercial operations of each leading franchise that competes
in this dynamic specialty market
– 5 leading companies in 5 countries in Europe
– 5 leading companies in the United States
Competitive Benchmarking of Leading Hepatitis Sales and Marketing Organizations in the
United States, Europe and Japan
Competitive Benchmarking of Leading Anti-TNF/Immunology Sales and Marketing
Organizations: Key Expenditures and Organizational Approaches in the United States
Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for
Leveraging the Medical Liaison Function in the United States and Europe
List of Syndicated Studies (cont’d)
Copyright 2013 by PharmaForce International R E A D I N G, P A
OVERALL ASSESSMENT
17
Managed Markets Structures and Strategies: Leading Companies’ Approaches
Integrated Delivery Networks (IDNs): Analysis of Leading Pharmaceutical Companies
Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for
Leveraging Health Economics Outcomes Research (HEOR) Capabilities
List of Syndicated Studies (cont’d)
Copyright 2013 by PharmaForce International R E A D I N G, P A
OVERALL ASSESSMENT
18
Contact Me
Copyright 2013 by PharmaForce International R E A D I N G, P A
For more information about PharmaForce International and
our Global Sales Force Deployment Analyzer database,
please contact Allison Becker or Marija Jukic at:
1-610-370-5640
or
abecker@pharmaforce.biz
mjukic@pharmaforce.biz
THANK YOU
19

Weitere ähnliche Inhalte

Andere mochten auch

SWOT FOR COMPETITIVE ASSESSMENT
SWOT FOR COMPETITIVE ASSESSMENTSWOT FOR COMPETITIVE ASSESSMENT
SWOT FOR COMPETITIVE ASSESSMENTGaphor Panimbang
 
Business Plan Training Session 5 Management
Business Plan Training Session 5   ManagementBusiness Plan Training Session 5   Management
Business Plan Training Session 5 Managementcbehn1
 
Business Plan Training Session 3: Competition
Business Plan Training Session 3: CompetitionBusiness Plan Training Session 3: Competition
Business Plan Training Session 3: Competitioncbehn1
 
Business Plan Training Session 2: Opportunity Assessment
Business Plan Training Session 2: Opportunity AssessmentBusiness Plan Training Session 2: Opportunity Assessment
Business Plan Training Session 2: Opportunity Assessmentcbehn1
 
Business Plan Training Session 1: Defining the Business
Business Plan Training Session 1: Defining the BusinessBusiness Plan Training Session 1: Defining the Business
Business Plan Training Session 1: Defining the Businesscbehn1
 
StoryPulse TOI Competitive Assessment
StoryPulse TOI Competitive AssessmentStoryPulse TOI Competitive Assessment
StoryPulse TOI Competitive AssessmentFOCALCXM
 
Connecting The Dots: Which pharma companies are succeeding in the social medi...
Connecting The Dots: Which pharma companies are succeeding in the social medi...Connecting The Dots: Which pharma companies are succeeding in the social medi...
Connecting The Dots: Which pharma companies are succeeding in the social medi...Ogilvy Health
 
Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPradeep555
 
Environmental Scanning:complete concept.
Environmental Scanning:complete concept.Environmental Scanning:complete concept.
Environmental Scanning:complete concept.Ashutosh Mishra
 
Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Zaki Sellam
 

Andere mochten auch (12)

SWOT FOR COMPETITIVE ASSESSMENT
SWOT FOR COMPETITIVE ASSESSMENTSWOT FOR COMPETITIVE ASSESSMENT
SWOT FOR COMPETITIVE ASSESSMENT
 
Business Plan Training Session 5 Management
Business Plan Training Session 5   ManagementBusiness Plan Training Session 5   Management
Business Plan Training Session 5 Management
 
Business Plan Training Session 3: Competition
Business Plan Training Session 3: CompetitionBusiness Plan Training Session 3: Competition
Business Plan Training Session 3: Competition
 
Business Plan Training Session 2: Opportunity Assessment
Business Plan Training Session 2: Opportunity AssessmentBusiness Plan Training Session 2: Opportunity Assessment
Business Plan Training Session 2: Opportunity Assessment
 
Business Plan Training Session 1: Defining the Business
Business Plan Training Session 1: Defining the BusinessBusiness Plan Training Session 1: Defining the Business
Business Plan Training Session 1: Defining the Business
 
StoryPulse TOI Competitive Assessment
StoryPulse TOI Competitive AssessmentStoryPulse TOI Competitive Assessment
StoryPulse TOI Competitive Assessment
 
Primary research
Primary researchPrimary research
Primary research
 
Benchmarking
BenchmarkingBenchmarking
Benchmarking
 
Connecting The Dots: Which pharma companies are succeeding in the social medi...
Connecting The Dots: Which pharma companies are succeeding in the social medi...Connecting The Dots: Which pharma companies are succeeding in the social medi...
Connecting The Dots: Which pharma companies are succeeding in the social medi...
 
Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma Industries
 
Environmental Scanning:complete concept.
Environmental Scanning:complete concept.Environmental Scanning:complete concept.
Environmental Scanning:complete concept.
 
Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model
 

Kürzlich hochgeladen

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 

Kürzlich hochgeladen (20)

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 

Competitive analysis and market research capabilities

  • 1. PharmaForce International Inc. Insightful Intelligence with a Global Reach Corporate Headquarters 2645 Perkiomen Avenue • Reading, PA 19606 • (610) 370-5640 • Fax (610) 370-5641 • www.pharmaforce.biz Competitive Analysis and Market Research Capabilities 2013
  • 2. 1 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES About PharmaForce International Copyright 2013 by PharmaForce International R E A D I N G, P A Specialists in competitive intelligence for the pharmaceutical, biotech and medical device industries Global leaders in identifying “everything and anything” that pharmaceutical and biotech companies want to know about the operations of their competitors • Competitive Monitoring • Syndicated Studies • Proprietary Projects
  • 3. 2 About PharmaForce International (cont’d) • Multi-lingual staff with direct experience in the pharmaceutical industry and business intelligence – Hundreds of years of combined industry experience as Sales Representatives, District Managers, Product Managers, Medical Information Specialists, Market Research Directors, Clinical Trial Coordinators, Business Analysts, Medical Liaisons and Country Business Unit Directors • Primary research capabilities, including the following languages: - Arabic - Italian - Chinese - Japanese - Croatian - Mandarin - Dutch - Portuguese - English - Russian - French - Serbian - German - Slovenian - Hindi - Spanish Copyright 20123by PharmaForce International R E A D I N G, P A COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 4. Examples of Countries Where PharmaForce Conducts Research Algeria Germany Poland Argentina Greece Portugal Australia Hong Kong Russia Austria Korea Saudi Arabia Belgium India South Africa Brazil Ireland Spain Canada Italy Sweden China Japan Switzerland Colombia Luxembourg Thailand Denmark Mexico Turkey Egypt Morocco United Kingdom Finland Netherlands United States France Norway Venezuela Copyright 2013 by PharmaForce International R E A D I N G, P A 3 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 5. 4 Selection of PharmaForce International‘s Clients Copyright 2013 by PharmaForce International R E A D I N G, P A COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 6. PharmaForce’s 360 Program • PharmaForce specializes in providing clients with a 360 perspective on the marketplace for their drugs Copyright 2013 by PharmaForce International R E A D I N G, P A 5 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Benchmarking capabilities include: - Sales force deployment - Target audience focus - Detailing intensity analysis (DIA) - Marketing expenditures for key drugs - Compensation plans - Key Account management personnel - Role of Medical Liaisons - Training programs - Product portfolio management, including FTEs by product - Medical Affairs structures and organizational approaches - Sales and Marketing structures and organizational approaches
  • 7. PharmaForce’s 360 Program (cont’d) • Pick and choose from the capabilities menu or receive tremendous cost savings by packaging a full suite of service • Our competitive intelligence capabilities track strategic planning through brand/ market assessments as well as therapeutic area outlooks Copyright 2013 by PharmaForce International R E A D I N G, P A 6 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Customer perception surveys Business research capabilities - KOL assessment - Sales force effectiveness - High prescriber perception analysis - Convention analysis and monitoring - Target physician audience profiling - Pipeline assessments
  • 8. Research Techniques • Unique combination of field research methodologies can be utilized in any therapeutic area(s)  Unstructured peer interviews conducted by professional staff  Questionnaire web-based surveys  Highly detailed benchmarking questionnaires  Expert panels • Through these survey techniques, PharmaForce has the ability to rapidly develop product and commercial strategy perceptions from key customer constituencies, such as:  KOLs  Physicians  High prescribers Copyright 2013 by PharmaForce International R E A D I N G, P A 7 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 9. Field-Tested Primary Source Research Approach Copyright 2013 by PharmaForce International R E A D I N G, P A  More than 90% of the information for any project is derived from one-on-one interviews with individuals in the industry • Includes current and former employees of target organizations  Interviewers draw a common bond with interview targets and engage in peer-to- peer discussions about topics of common interest • Supplemented with searches of all relevant electronic and printed databases, including PharmaForce’s proprietary databases developed over the past two decades 8 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Database of qualified contacts in the pharmaceutical industry exceeds 50,000 worldwide Includes personnel in almost every sales and marketing function from sales representatives to senior management
  • 10. Field-Tested Primary Source Research Approach (cont’d) Copyright 2013 by PharmaForce International R E A D I N G, P A 9 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES • Strong interviewing skills come into play with the middle 50% as key partial pieces of data are culled from their limited responses • Ability to trade data on previously researched companies dramatically increases level of cooperation Typically, 25% of interviewees participate willingly, while another 25% refuse to participate • One-on-one discussions with multiple knowledgeable sources result in verification of data • Previous research experience on the topics allows for the widest possible knowledge base of the target deliverables and key resources Triangulation of data from contacts who are customers, suppliers and company employees results in multiple confirmations of findings from all perspectives All employees participate in an ongoing training program to improve interviewing techniques and identify the latest trends in the industry Member of PBIRG and EphMRA
  • 11. Interviewing Methodology Copyright 2013 by PharmaForce International R E A D I N G, P A Target company Competitors Former employees Clinical trial investigators Formulary managers Advertising agencies Physicians, thought leaders, hospitals and other medical personnel Advocacy and cooperative groups, convention personnel, CME development firms, etc. Existing database 10 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 12. Competitive Advantages of Using PharmaForce Copyright 2013 by PharmaForce International R E A D I N G, P A Key competitive advantages of utilizing PharmaForce for your competitive analysis and market research needs include: 11 Pharma industry- experienced staff who are veterans of hundreds of projects in the pharmaceutical and biotech industries One-on-one interviewing with KOLs, physicians and patients to obtain the full perspective on your therapeutic area Customized reports available to target any company, country, therapy area and brand of interest! Established relationships with over 50,000 industry personnel to gain crucial insights on your key competitors 360° view into internal structures, market spending, insights, benchmarks and best practices of industry leaders worldwide COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 13. Why Companies Use PharmaForce’s Studies Copyright 2013 by PharmaForce International R E A D I N G, P A 12 Maximize the success of product launches through key messaging Increase sales force effectiveness Allocate marketing resources Restructure/expand/add sales forces or other departments Satisfy the needs of key customer constituencies Understand aspects of lifecycle management and product position Overall, PharmaForce’s studies provide more information to better deploy resources COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 14. “Your oncology sales force and marketing expenditure benchmarking is the gold standard in the industry. Our company has purchased the study for 6 consecutive years and could not determine our marketing budgets or sales force POAs without it” – Global Market Research Director, Top 5 Pharma Company “PharmaForce’s competitive intelligence data is by far the most accurate data that we have ever used. Senior management love it. We would not use any other competitive intelligence firm” – Market Intelligence Director, Billion Dollar Specialty Pharma Company “Once we used PharmaForce’s benchmarking data in one therapeutic area, I immediately knew that we had to use it in every other therapeutic area in our company” – Director, Global Market Analytics, Top 10 Pharma Company “PharmaForce works within this company’s budget constraints to provide partial data from multiple syndicated studies” – Up-and-coming biotech company launching its first drug Client Testimonials Copyright 2013 by PharmaForce International R E A D I N G, P A 13 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 15. Assisting an Emerging Biotech Assess the Competitive Landscape for the First Time and Develop Recommendations for Establishing a Commercial Presence in 6 Different Countries Worldwide Benchmarking of Marketing Expenditures by Product or Franchise Analysis of Drug Launch Plans Assessment of Potential Biotech Partnership/Acquisition Opportunities Competitive Assessment of Patient Marketing Programs and Materials Analysis of Medical Services Departments Globally Health Economics Outcomes Research (HEOR) Strategies Benchmarking of the Managed Care Function at Leading Pharma Companies Assessment of KOL Opinions on Best Practices in Advisory Board Sessions Competitive Monitoring of the U.S. Vaccines Market Analysis of Clinical Trial and Phase IV Strategies for Select Products Analysis of Sampling Programs and Detailing Messages Benchmarking of the Medical Affairs Function Supporting Leading Products Benchmarking of Speakers’ Bureaus and Advisory Board Management Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Targeting the Hospital/IDN Market Customer Examples of Types of Studies Conducted by PharmaForce Copyright 2013 by PharmaForce International R E A D I N G, P A 14 COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES
  • 16. 15
  • 17. PharmaForce International Global Deployment Analyzer: a powerful web-based program that allow clients to access up-to-date information on leading pharmaceutical sales forces around the globe at www.deploymentanalyzer.com – 60 leading companies’ sales forces in the United States – 25 leading companies’ sales forces in 10 countries in Europe – 25 leading companies’ sales forces in Japan – 12 leading companies’ sales forces in Argentina, Brazil and Mexico – 13 leading companies’ sales forces in India Competitive Benchmarking of Leading Oncology Sales and Marketing Organizations, providing worldwide perspective on sales and marketing operations of leading oncology competitors around the globe – 14 leading companies in 5 countries in Europe – 21 leading companies in the United States – 11 leading companies in Japan – 10 leading companies in 4 countries in Latin America List of Syndicated Studies Copyright 2013 by PharmaForce International R E A D I N G, P A OVERALL ASSESSMENT 16
  • 18. Competitive Benchmarking of Leading Multiple Sclerosis Sales and Marketing Organizations, covering commercial operations of each leading franchise that competes in this dynamic specialty market – 5 leading companies in 5 countries in Europe – 5 leading companies in the United States Competitive Benchmarking of Leading Hepatitis Sales and Marketing Organizations in the United States, Europe and Japan Competitive Benchmarking of Leading Anti-TNF/Immunology Sales and Marketing Organizations: Key Expenditures and Organizational Approaches in the United States Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Leveraging the Medical Liaison Function in the United States and Europe List of Syndicated Studies (cont’d) Copyright 2013 by PharmaForce International R E A D I N G, P A OVERALL ASSESSMENT 17
  • 19. Managed Markets Structures and Strategies: Leading Companies’ Approaches Integrated Delivery Networks (IDNs): Analysis of Leading Pharmaceutical Companies Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Leveraging Health Economics Outcomes Research (HEOR) Capabilities List of Syndicated Studies (cont’d) Copyright 2013 by PharmaForce International R E A D I N G, P A OVERALL ASSESSMENT 18
  • 20. Contact Me Copyright 2013 by PharmaForce International R E A D I N G, P A For more information about PharmaForce International and our Global Sales Force Deployment Analyzer database, please contact Allison Becker or Marija Jukic at: 1-610-370-5640 or abecker@pharmaforce.biz mjukic@pharmaforce.biz THANK YOU 19